SILPURAN

USPTO USPTO 2006 SECTION 71 ACCEPTED

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark SILPURAN was filed as Word mark on 11/22/2006 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 02/10/2009. The current status of the mark is "SECTION 71 ACCEPTED".

Trademark Details

Trademark form Word mark
File reference 79038439
Register number 3572724
Application date November 22, 2006
Publication date November 25, 2008
Entry date February 10, 2009

Trademark owner

Hanns-Seidel-Platz 4
81737 München
DE

Trademark representatives

goods and services

1 Unprocessed plastics; chemical compounds used in the manufacture of plastics, namely, compounds that crosslink to form plastics; unprocessed plastics in the form of powders, solutions, dispersions and granules; chemicals, auxiliaries being chemicals, chemical additives and catalysts used in the manufacture of plastics; silanes; silicic-acid esters; silicones for general industrial use; carbosilanes; silazanes; embedding compounds, namely, on the base of organosilicon compounds for general industrial use; moulding compounds, namely, on the base of organosilicon compounds for general industrial use; chemical agents for impregnating, binding or coating of textiles, furs and leather, non-wovens and fabrics; antifoam agents; chemical release agents for general industrial use; chemical agents for thickening and thixotropic effects; chemical polymer coating agents for paper, mineral materials, fillers and pigments; chemical binding agents for glues, adhesives; chemical additives for cosmetic preparations; plasticisers for plastics; chemical adhesion promoters, namely, on the base of organosilicon compounds; active substances on the base of organosilicon compounds, chemical raw materials and chemical auxiliaries, all for use in the manufacture of pharmaceuticals, excluding bacteriostat and fungistat additives
5 Organosilicon compounds as additives and auxiliaries and as carriers, sold as integral components for pharmaceuticals for use in the treatment of infectious diseases, injuries, degenerative conditions, tumor, mental illnesses, psychosomatic illnesses, diseases of civilization, namely, venereal diseases, cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, nervous system diseases, viral diseases, diabetes, cancer, AIDS and infectious diseases, immune and autoimmune diseases, inflammatory diseases, deficiencies, namely, nutritional, cancer and inborn, vitamin, and immununilogical deficiencies, scars, wounds, pain, ophthalmic diseases and conditions, for use in the replacement or supplement of body parts with defects caused by trauma and disease or by birth and in the replacement or supplement of body parts lost by trauma, disease, or missing from birth; material for stopping teeth; dental impression compounds; plastics and plastic articles for medical use, namely, surgical cloth and medical dressings
17 Semi-processed plastics and plastic goods in the form of films, sheets, tubes, bars or rods; plastic goods for use as industrial or commercial sealing, packing and insulating material, namely, plastic films and plastic sheets; plastics in the form of blocks, sheets, films, rods, flexible pipes, fibres not for textile use for general industrial use; thermoplastic synthetic resins in film, sheet, tube, bar, pellet, block, or rod form for use in further manufacture; sealants for joints; insulating paints and lacquers; insulating oils for general industrial use; plastic gaskets for general industrial use; plastic yarns, fibres and threads not for textile use

ID: 1379038439